1. Biomarkers for Immunotherapy of Oral Squamous Cell Carcinoma: Current Status and Challenges
   Alhadi Almangush et al, 2021, Frontiers in Oncology CrossRef
2. Neoadjuvant chemotherapy alters the balance of effector to suppressor immune cells in advanced ovarian cancer
   Alexandra Leary et al, 2021, Cancer Immunology, Immunotherapy CrossRef
3. Пухлиноінфільтруючі лімфоцити: нові виклики імунотерапії солідних пухлин
   O.Yu. Nikolaieva, 2023, Practical oncology CrossRef
4. Epithelial ovarian cancer is infiltrated by activated effector T cells co-expressing CD39, PD-1, TIM-3, CD137 and interacting with cancer cells and myeloid cells
   Elena Tassi et al, 2023, Frontiers in Immunology CrossRef
5. The prognostic significant of tumor budding, tumor stroma ratio and tumor-infiltrating lymphocytes in gallbladder adenocarcinoma
   İlke Evrim SEÇİNTİ et al, 2022, Journal of Contemporary Medicine CrossRef
6. High expression of CD8 in the tumor microenvironment is associated with PD-1 expression and patient survival in high-grade serous ovarian cancer
   Fatma Ölmez et al, 2022, Journal of Turkish Society of Obstetric and Gynecology CrossRef
7. A disulfidptosis-related lncRNA prognostic model to predict survival and response to immunotherapy in lung adenocarcinoma
   Hai-Bo Zhang et al, 2023, Frontiers in Pharmacology CrossRef
8. Comparative Evaluation of Tumor-Infiltrating Lymphocytes in Companion Animals: Immuno-Oncology as a Relevant Translational Model for Cancer Therapy
   Christopher J. Pinard et al, 2022, Cancers CrossRef